Acumen Pharmaceuticals, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Jun 2020 | — | $-2.0M | $-2.0M |
| Sep 2020 | — | $-2.5M | $-2.5M |
| Mar 2021 | — | $-3.8M | $-27.0M |
| Jun 2021 | — | $-3.4M | $-61.4M |
| Sep 2021 | — | $-3.9M | $-3.9M |
| Dec 2021 | — | $-8.4M | $-8.3M |
| Mar 2022 | — | $-9.2M | $-9.1M |
| Jun 2022 | — | $-10.4M | $-10.2M |
| Sep 2022 | — | $-11.4M | $-10.7M |
| Dec 2022 | — | $-14.2M | $-12.9M |
| Mar 2023 | — | $-13.1M | $-11.3M |
| Jun 2023 | — | $-13.5M | $-11.6M |
| Sep 2023 | — | $-16.0M | $-13.0M |
| Dec 2023 | — | $-18.5M | $-16.5M |
| Mar 2024 | — | $-17.8M | $-14.9M |
| Jun 2024 | — | $-24.4M | $-20.5M |
| Sep 2024 | — | $-32.3M | $-29.8M |
| Dec 2024 | — | $-39.6M | $-37.2M |
| Mar 2025 | — | $-30.4M | $-28.8M |
| Jun 2025 | — | $-41.8M | $-41.0M |
| Sep 2025 | — | $-26.5M | $-26.5M |
| Dec 2025 | — | $-25.2M | $-25.1M |
| Mar 2026 | — | $-21.1M | $-20.7M |
| Jun 2026 | — | $-32.6M | $-32.7M |